Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by JACOBS, E. C.
Right arrow Articles by KUHNS, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by JACOBS, E. C.
Right arrow Articles by KUHNS, D. M.
(Chest. 1952;22:523-528.)
© 1952 American College of Chest Physicians

Avascularity of Tuberculous Lesions

A Major Problem in Therapy

EUGENE C. JACOBS (MC), U.S.A., F.C.C.P.1 and DWIGHT M. KUHNS (MC), U.S.A.2

1 Chief, Laboratory Service, Walter Reed Army Hospital., Office of the Surgeon General, Department of the Army.
2 Office of the Surgeon General, Department of the Army.

The extensive thrombosis and obliterative endarteritis of vessels entering chronic tuberculous areas of disease produce essentially avascular lesions. Other closely associated pathological changes, ischemic (caseous) necrosis and fibrosis, further increase the avascularity. There is some evidence that streptomycin penetrates these pathological barriers; however, when it enters in less than therapeutic concentrations, it is neither tuberculostatic nor tuberculocidal, and the emergence of resistant tubercle bacilli results.

Efforts are presently being made to penetrate pathological barriers by various methods so as to allow drugs to come into direct contact with tubercle bacilli. The following methods have been tried: cavernostomy, potassium iodide, antihistaminics, detergents, streptokinase and tuberculin. Of these, tuberculin appears to revascularize tuberculous lesions, exposing tubercle bacilli to therapeutic levels of chemotherapeutic agents.

It appears that further effort must be made to penetrate pathological barriers of chronic tuberculosis, if the full effectiveness of present and future chemotherapeutic agents is to be obtained.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1952 by the American College of Chest Physicians.